Back to News
Market Impact: 0.2
Zacks Initiates Coverage of Interlink With Neutral Recommendation
Source: zacks.com
Analyst InsightsHealthcare & BiotechCompany FundamentalsM&A & Restructuring
Zacks initiated coverage of LINK with a Neutral rating, marking the first Wall Street coverage of the stock. The firm cited improving profitability, growth in medical and standard products, and acquisitions as positives, offset by customer concentration risk and weak industrial end-market conditions.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.00
More News
- Exclusive-Malaysia talks to rival airlines as it monitors AirAsia’s financial health, sources say
- Factbox-Private equity, foreign investors fuel Aussie M&A activity in 2026
- Australia’s Reliance Worldwide agrees to Brookfield’s $2.9 billion buyout bid
- Trip.com swings to Q2 loss after $763 million antitrust penalty
- Wells Fargo sees improvement in a key metric — plus, Lilly gets praise beyond GLP-1s
- Reliance Worldwide shares hit 1-year high on Brookfield’s $2.9 bln deal
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Can ChatGPT or Claude Replace a Research Platform?
- How the 2026 Milan-Cortina Winter Olympics Will Reshape Company Revenues and Stock Performance